121 related articles for article (PubMed ID: 2915120)
1. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. Implications for mechanisms of action.
Zimmerman RJ; Marafino BJ; Chan A; Landre P; Winkelhake JL
J Immunol; 1989 Feb; 142(4):1405-9. PubMed ID: 2915120
[TBL] [Abstract][Full Text] [Related]
2. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.
Zimmerman RJ; Chan A; Leadon SA
Cancer Res; 1989 Apr; 49(7):1644-8. PubMed ID: 2924312
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.
Hauser GJ; McIntosh JK; Travis WD; Rosenberg SA
Cancer Res; 1990 Jun; 50(12):3503-8. PubMed ID: 2340500
[TBL] [Abstract][Full Text] [Related]
4. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA
Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349
[TBL] [Abstract][Full Text] [Related]
5. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo.
Obrador E; Navarro J; Mompo J; Asensi M; Pellicer JA; Estrela JM
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):183-9. PubMed ID: 9224645
[TBL] [Abstract][Full Text] [Related]
6. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA
J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720
[TBL] [Abstract][Full Text] [Related]
7. [Effect of 131I-labeled recombinant human tumor necrosis factor-alpha on the nude mice bearing human hepatoma].
Long YH; Li YC; Mi YX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):787-92. PubMed ID: 19950584
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
[TBL] [Abstract][Full Text] [Related]
9. Studies of the mechanisms of toxicity of the administration of recombinant tumor necrosis factor alpha in normal and tumor-bearing mice.
Krosnick JA; McIntosh JK; Mulé JJ; Rosenberg SA
Cancer Immunol Immunother; 1989; 30(3):133-8. PubMed ID: 2598182
[TBL] [Abstract][Full Text] [Related]
10. [Effects of recombinant human tumor necrosis factor-alpha on HL-60 cells in vitro and in vivo].
Liu X; Chen YZ; Wu Y; Huang MJ; Yang DL; Guo JR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):477-80. PubMed ID: 16800924
[TBL] [Abstract][Full Text] [Related]
11. [An in vitro and in vivo study of antitumor effects of rHTNF-alpha on human ovarian cancer].
Zhao EF; Zhou MQ; Fu CY
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):273-6. PubMed ID: 7805556
[TBL] [Abstract][Full Text] [Related]
12. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
Haranaka K; Sakurai A; Satomi N
J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factor.
Satomi N; Sakurai A; Haranaka R; Haranaka K
J Biol Response Mod; 1988 Feb; 7(1):54-64. PubMed ID: 3373234
[TBL] [Abstract][Full Text] [Related]
15. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
Postma NS; Crommelin DJ; Eling WM; Zuidema J
J Pharmacol Exp Ther; 1999 Jan; 288(1):114-20. PubMed ID: 9862761
[TBL] [Abstract][Full Text] [Related]
16. Effects of TNF alone or in combination with chemotherapeutic agents on human ovarian cancers in vitro and in nude mice.
Zhao E; Zhou M; Fu C; Shen B; Zhang Q; Lian L
Chin Med J (Engl); 1995 Aug; 108(8):571-5. PubMed ID: 7587485
[TBL] [Abstract][Full Text] [Related]
17. Effects of antitumor activity and protection of shock symptoms by a traditional Chinese medicine (sho-saiko-to) in recombinant human tumor necrosis factor administered mice.
Sakaguchi S; Furusawa S; Yokota K; Sasaki K; Takayanagi M; Takayanagi Y
Biol Pharm Bull; 1996 Nov; 19(11):1474-8. PubMed ID: 8951167
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumour cell sensitivity to TNF-induced oxidative stress and cytotoxicity: role of glutathione.
Obrador E; Navarro J; Mompo J; Asensi M; Pellicer JA; Estrela JM
Biofactors; 1998; 8(1-2):23-6. PubMed ID: 9699004
[TBL] [Abstract][Full Text] [Related]
19. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.
McIntosh JK; Jablons DM; Mulé JJ; Nordan RP; Rudikoff S; Lotze MT; Rosenberg SA
J Immunol; 1989 Jul; 143(1):162-7. PubMed ID: 2499626
[TBL] [Abstract][Full Text] [Related]
20. Human tumor necrosis factor-alpha mutant RGD-V29 (F4614) shows potent antitumor activity and reduced toxicity against human tumor xenografted nude mice.
Kuroda K; Miyata K; Fujita F; Koike M; Fujita M; Nomura M; Nakagawa S; Tsutsumi Y; Kawagoe T; Mitsuishi Y; Mayumi T
Cancer Lett; 2000 Oct; 159(1):33-41. PubMed ID: 10974403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
